** Shares of ReNerve RNV.AX rise 9.5% to A$0.115
** Stock set for its strongest session since March 28, if current trends hold
** The medical devices maker forms a partnership with NetCentrix Ventures to establish and develop operations in the Indian healthcare market
** Co says the Indian nerve repair market currently valued at $115 million, has a growth rate of 18.5% and is expected to nearly double by 2030
** Stock down 34.3% YTD, including current session's moves
(Reporting by Manasi Dasa in Bengaluru)
((Manasi.DasaSundeep@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。